532488:BOM
Divi's Laboratories Ltd
₹6,625.45
arrow_upward
+0.47%(+31.00) 1D
Jun 5, 3:30:00 PM GMT+5:30 · INR
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 532488...
Open
₹6,653.40
High
₹6,653.40
Low
₹6,568.60
Mkt. cap
1.76T
Avg. vol.
26.37K
Volume
122.83K
Dividend
0.45%
Quarterly dividend
₹7.50
Ex-dividend date
Jul 24, 2026
P/E ratio
68.48
52-wk high
₹7,077.70
52-wk low
₹5,637.50
EPS
₹96.75
Shares outstanding
265.47M
No. of employees
11K
Open
₹6,653.40
High
₹6,653.40
Low
₹6,568.60
Mkt. cap
1.76T
Avg. vol.
26.37K
Volume
122.83K
Dividend
0.45%
Quarterly dividend
₹7.50
Ex-dividend date
Jul 24, 2026
P/E ratio
68.48
52-wk high
₹7,077.70
52-wk low
₹5,637.50
EPS
₹96.75
Shares outstanding
265.47M
No. of employees
11K
News stories
From sources across the web
Moomoo
·
8 minutes ago
S&P 500 Sees $1.8 Trillion Wipeout, Nasdaq Tallies Biggest Point Drop on Record: What Investors Need to Know About Friday's Selloff
Simply Wall Street
·
27 minutes ago
Have Insiders Sold NovoCure Shares Recently?
MarketWatch
·
21 minutes ago
S&P 500 companies can’t stop talking about higher oil prices. But few say they’ll actually hit profits.
Yahoo Finance
·
1 hour ago
Nasdaq (NASDAQ:NDAQ) Could Be A Buy For Its Upcoming Dividend
Profile
Divi's Laboratories Limited is an Indian multinational pharmaceutical company and producer of active pharmaceutical ingredients and intermediates, headquartered in Hyderabad. The company manufactures and custom synthesizes generic APIs, intermediates. The company also manufactures and supplies nutraceutical ingredients through its subsidiary, Divi's Nutraceuticals. Divi's Laboratories is India's fourth largest publicly listed pharmaceutical company by market capitalization. Wikipedia
About Divi's Laboratories Ltd
AI content may include mistakes. Learn more